Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

  title={Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study},
  author={J. S. Malik Peiris and C. M. Chu and V. C. C. Cheng and Ks Chan and I. F. N. Hung and L. L. M. Poon and Kin Ip Law and Bsf Tang and Tyw Hon and C H F Chan and K. H. Chan and Jsc Ng and Bj Zheng and W. K. Ng and Rwm Lai and Y. J. Guan and K-Y. Yuen},
  journal={Lancet (London, England)},
  pages={1767 - 1772}

Figures and Tables from this paper

Viral Replication in the Nasopharynx Is Associated with Diarrhea in Patients with Severe Acute Respiratory Syndrome
  • V. Cheng, I. Hung, K. Yuen
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2004
The lung and the gastrointestinal tract may react differently to SARS coronavirus infection, and additional investigation of the role of SARS coroneravirus in the pathogenesis of diarrhea in patients with SARS should be conducted.
Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019
Lymphocyte, especially T lymphocyte, in severe and critical patients showed a dramatic decrease, and application of lower dose corticosteroids could inhibit IL-6 production (a representative of cytokines) as effectively as a higher dose.
Initial viral load and the outcomes of SARS
Evidence is found that higher initial viral load is independently associated with worse prognosis in SARS, and Mortality data for patients with SARS should be interpreted in light of age, comorbidity and viral load.
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19
The prodromal symptoms of COVID-19 were mild and most patients did not have limitations of daily activity, and these findings could be plausible explanations for the easy and rapid spread of SARS-CoV-2 in the community.
Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study
Higher viral loads and stronger antibody responses are related to more severe disease status in patients with SARS-CoV-2 infection, and the antibodies persisted in the recovered patient for more than 6 months so that the vaccine may provide protection against SARS.
Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster
It is shown that COVID-19 can often present as a common cold-like illness, and SARS-CoV-2 can actively replicate in the upper respiratory tract, and is shed for a prolonged time after symptoms end, including in stool.
Viral shedding and antibody response in 37 patients with MERS-coronavirus infection
The timing and intensity of respiratory viral shedding in MERS patients closely matches that of Severe Acute Respiratory Syndrome (SARS) patients and neutralizing antibodies do not suffice to clear the infection.
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt
Older age and elevated serum ferritin were significant risk factors for severe COVID-19, and testing for presence of other co-infecting agents should be considered, and prompt treatment should be carried out according to the antimicrobial sensitivity reports.
IgG antibody seroconversion and the clinical progression of COVID-19 pneumonia: A retrospective, cohort study
The respiratory failure due to COVID-19 viral pneumonia observed in week 2 may be related to an antibody-related mechanism rather than uncontrolled viral replication.


Rapid Diagnosis of a Coronavirus Associated with Severe Acute Respiratory Syndrome (SARS)
A real-time quantitative PCR assay to detect this virus in clinical specimens is reported, confirming the diagnosis of SARS in all patients by the presence of antibodies against the novel coronavirus in the serum.
A major outbreak of severe acute respiratory syndrome in Hong Kong.
SARS is a serious respiratory illness that led to significant morbidity and mortality in this cohort of 138 cases of suspected SARS during a hospital outbreak in Hong Kong.
A cluster of cases of severe acute respiratory syndrome in Hong Kong.
SARS appears to be infectious in origin, and Fever followed by rapidly progressive respiratory compromise is the key complex of signs and symptoms from which the syndrome derives its name.
Prevention of Experimental Coronavirus Colds with Intranasal α-2b Interferon
Prophylactic intranasal rIFN effectively shortened the duration and reduced the severity of coronavirus cold symptoms.
A novel coronavirus associated with severe acute respiratory syndrome.
A novel coronavirus is associated with this outbreak of severe acute respiratory syndrome, and the evidence indicates that this virus has an etiologic role in SARS.
Identification of severe acute respiratory syndrome in Canada.
SARS appears to be of viral origin, with patterns suggesting droplet or contact transmission, and the role of human metapneumovirus, a novel coronavirus, or both requires further investigation.
Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome.
A differential role for T lymphocytes in the development of fibrosis associated with BOOP versus ARDS is demonstrated and it is suggested that interferon-gamma plays a key role in the fibrotic process and that elevated levels of interferons are associated with a continuum from least to more severe fibrosis.
Atypical Pneumonia*
The existence of cases of pneumonia distinct anatomically from lobar pneumonia or bronchopneumonia and possessing a correspondingly diverse clinical course and aetiology has, of course, been